INS and Hypoglycemia: The global Hypoglycemia Assessment Tool (HAT) study, which was designed to determine the incidence of hypoglycemia in a global insulin-treated patient population, demonstrated that the real-world incidence of hypoglycemia is high compared with rates reported from randomized clinical trials.